Hydroxyurea does not increase infection risk in children with sickle cell anemia
Children living with sickle cell anemia have no higher incidence of clinically diagnosed infections when treated with hydroxyurea.
Read original article on The Medical News →Related news
-
T-cell research reveals paths to better vaccines for COVID-19 and beyond
-
New signaling pathway enhances blood stem cell transplantation outcomes
-
Insuficiência cardíaca: do diagnóstico ao tratamento | VEJA e Cuide-se
-
Cutting sugary drinks helps reduce childhood obesity, study finds
-
The 9 Best Amazon Bedsheets for a Luxurious Night’s Sleep
-
Despite the controversy, data centers could be attractive to struggling rural towns
-
Cyberbullying acts as an extension of in-person school violence
-
Masked high blood pressure linked to higher risk of falls in older adults